FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Justice Department Probe on Philips Respironics Recall

The Department of Justice subpoenas Philips Respironics and certain other Philips subsidiaries in the U.S. for information on the events that led to t...

Federal Register

Export Notification/Recordkeeping Info Collection

Federal Register notice: FDA sends to OMB an information collection extension entitled Export Notification and Recordkeeping Requirements.

Federal Register

Autofluorescence Detection Device is Class 2

Federal Register notice: FDA classifies the autofluorescence detection device for general surgery and dermatological use into Class 2 (special control...

Human Drugs

FDA Hits Wedgewood Connect with 483 After Inspection

FDA issues a four-item Form FDA-483 to Wedgewood Connect after an inspection of its San Jose, CA drug manufacturing facility cited significant GMP vio...

Federal Register

Xenotransplantation Guide Information Collection

Federal Register notice: FDA sends to OMB an information collection extension entitled Public Health Service (PHS) Guideline on Infectious Disease Iss...

FDA Probes DTC Promotional Claims Tradeoffs

CDER's Office of Prescription Drug Promotion seeks comments on a research proposal to understand the Tradeoff Analysis of Prescription Drug Product Cl...

Human Drugs

CMC Issues Hinder Axsome NDA on Migraine Drug

Axsome Therapeutics expects to receive a complete response letter on its NDA for migraine drug AXS-07 (meloxicam-rizatriptan) due to FDA-identified ch...

Medical Devices

Lab Test Firms, Others Plead Guilty in Kickback Scheme

Eleven defendants, including the founders of several lab companies, plead guilty in a $300 million scheme to pay kickbacks to induce medical professio...

Human Drugs

Gileads Veklury OKd for Covid Pediatric Patients

FDA expands the approval of Gilead Sciences Veklury (remdesivir) to include treating Covid-19 pediatric patients 28 days of age and older weighing at ...

Human Drugs

Ardelyx Gets Panel Review on Tenapanor Appeal

CDERs Office of New Drugs says it will convene its Cardiovascular and Renal Drug Advisory Committee to hear an appeal from Ardelyx of a complete respo...